Breathe Well Live Well
Condition: Cough
Interventions: Drug: Procaterol; Drug: Placebo
Sponsors: Mahidol University; Thai Otsuka Pharmaceutical Co.,Ltd.
Not yet recruiting – verified January 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Biological: Benralizumab; Biological: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Persistent asthma related to increased low-density granulocyte levels
Healio Researchers studied 20 patients with intermittent (n=9) or mild persistent (n=11) asthma, 20 patients with moderate persistent (MoP; n=10) or severe persistent (SP; n=10) asthma, and 20 controls with no history of allergy or asthma. All participants … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Fluticasone Furoate/Vilanterol 100/25 mcg via ELLIPTA inhaler; Drug: Placebo inhalation powders via ELLIPTA inhaler; Drug: Fluticasone Propionate/Salmeterol 250/50 mcg via ACCUHALER/DISKUS inhaler; Drug: Placebo inhalation powder via ACCUHALER/DISKUS inhaler; Drug: Fluticasone Propionate 250 mcg via ACCUHALER/DISKUS inhaler
Sponsor: GlaxoSmithKline
Not yet recruiting – verified November 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
MESA Analysis Uncovers Link Between Persistent Asthma and Cardiovascular …
Medscape CHICAGO, IL — An analysis from the Multi-Ethnic Study of Atherosclerosis (MESA) suggests there may be an association between persistent asthma and the risk of cardiovascular disease. In a new study presented this week at the American Heart Association … |
View full post on asthma – Google News
|
Once-Daily Fluticasone Furoate May Be Effective for Persistent Asthma
Monthly Prescribing Reference A new study published in the journal Respiratory Research evaluates the use of a once-daily dosing regimen for the inhaled corticosteroid (ICS) fluticasone furoate vs. placebo in patients with asthma uncontrolled by non-inhaled corticosteroids … |
View full post on asthma – Google News
Condition: Persistent Asthma
Interventions: Drug: Fluticasone propionate Multidose Dry Powder Inhaler (Fp MDPI); Drug: Fluticasone propionate /salmeterol MDPI (FS MDPI); Drug: Fluticasone propionate HFA Inhalation Aerosol; Drug: Fluticasone propionate/salmeterol dry powder formulation
Sponsors: Teva Pharmaceutical Industries; Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting – verified June 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
A new treatment option for people with severe – persistent asthma
WNYT It's well known that asthma rates keep climbing. A recent report by the New York State Comptroller's Office found Medicaid costs related to asthma were $532 million last year. That's an increase of more than 26 percent over five years. Enter, a new … |
View full post on asthma – Google News
|
Asthma in children needs persistent care
Toledo Blade “Asthma is a chronic disease and should be treated as such,” says Pierre Vauthy, M.D., a ProMedica Physicians pediatric pulmonologist who has cared for children with asthma and other lung conditions for more than 30 years. “Compared to when I started … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Budesonide Inhalation Aerosol (PT008) Dose 1; Drug: Budesonide Inhalation Aerosol (PT008) Dose 2; Drug: Budesonide Inhalation Aerosol (PT008) Dose 3; Drug: Budesonide Inhalation Aerosol (PT008) Dose 4; Drug: Placebo
Sponsor: Pearl Therapeutics, Inc.
Not yet recruiting – verified April 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days